Jagsonpal Pharmaceuticals vs Nifty 50: Returns Compared
- September 30, 2026
- Posted by: Kunal Singla
- Category: Market
Jagsonpal Pharmaceuticals share price Rs 234.71 on NSE. Jagsonpal Pharmaceuticals vs Nifty 50 over 1 year: +7.04% vs -7.7%. 52-week high Rs 264.50, low Rs 155.00.
Quick Answer
Jagsonpal Pharmaceuticals vs Nifty 50 shows Jagsonpal Pharmaceuticals ahead of the benchmark on a one-year view, gaining +7.04% against the Nifty 50’s -7.7%. Over the longer term the stock has also stayed ahead of the index, a pattern that reflects its underlying business momentum rather than a single quarter’s swing. Investors comparing the two should also weigh Jagsonpal Pharmaceuticals’s trading liquidity, valuation and sector context rather than relying on returns alone.
Jagsonpal Pharmaceuticals vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Jagsonpal Pharmaceuticals trades on the NSE under the symbol JAGSNPHARM, and its 1M return of -2.55% compares with the Nifty 50’s -5.67% over the same period.
The Jagsonpal Pharmaceuticals vs Nifty 50 comparison matters because Jagsonpal Pharmaceuticals is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Jagsonpal Pharmaceuticals share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, 3 years, 5 years, using NSE closing data.
Also read – Jaiprakash Power Ventures vs Nifty 50: Share Price Performance Compared
Click Here – Get Free Investment Predictions
Jagsonpal Pharmaceuticals vs Nifty 50: Performance at a Glance
The table below sets out Jagsonpal Pharmaceuticals vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 30 September 2026.
| Time Frame | Jagsonpal Pharmaceuticals Return | Nifty 50 Return | Difference |
|---|---|---|---|
| 1 Month | -2.55% | -5.67% | +3.12% pp |
| 3 Months | -1.34% | -5.37% | +4.03% pp |
| 6 Months | +26.42% | +0.16% | +26.26% pp |
| 1 Year | +7.04% | -7.7% | +14.74% pp |
| 3 Years | +39.92% | +15.67% | +24.25% pp |
| 5 Years | +277.1% (Jagsonpal Pharmaceuticals) | +29.57% (Nifty 50) | +247.54% pp |
On the Jagsonpal Pharmaceuticals vs Nifty 50 scorecard, Jagsonpal Pharmaceuticals has stayed ahead of the index over the most recent one-year window. Over the longer term the stock has also stayed ahead of the index, a pattern that reflects its underlying business momentum rather than a single quarter’s swing.
Check the Univest Screener for live Jagsonpal Pharmaceuticals and Nifty 50 data
Why the Jagsonpal Pharmaceuticals vs Nifty 50 Gap Exists
Jagsonpal Pharmaceuticals’s stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Jagsonpal Pharmaceuticals vs Nifty 50 return table above.
A second factor behind the Jagsonpal Pharmaceuticals vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Jagsonpal Pharmaceuticals’s price sharply in either direction over short periods, while the Nifty 50’s return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock’s swings.
Download the Univest iOS App or Univest Android App to track Jagsonpal Pharmaceuticals and Nifty 50 live on the go.
Jagsonpal Pharmaceuticals vs Nifty 50: Has Jagsonpal Pharmaceuticals Beaten the Benchmark?
Jagsonpal Pharmaceuticals has beaten the Nifty 50 over the past year, gaining +7.04% against the index’s -7.7% over the same period.
Also read – Jayshree Tea vs Nifty 50: Share Price Performance Compared
Risks of the Jagsonpal Pharmaceuticals vs Nifty 50 Comparison
Reading too much into a Jagsonpal Pharmaceuticals vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Jagsonpal Pharmaceuticals carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50’s more liquid, blended profile. A stock’s 52-week range of Rs 155.00 to Rs 264.50 also shows the kind of volatility that a single-stock investment carries relative to a broad index.
Conclusion
Jagsonpal Pharmaceuticals vs Nifty 50 highlights how a single stock’s return path can differ from a diversified benchmark over different time horizons. Investors weighing the Jagsonpal Pharmaceuticals vs Nifty 50 record should factor in Jagsonpal Pharmaceuticals’s volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Has Jagsonpal Pharmaceuticals outperformed the Nifty 50 in the last year?
Ans. Yes. Jagsonpal Pharmaceuticals gained +7.04% over the past year while the Nifty 50 returned -7.7% over the same period, based on NSE closing prices to 30 September 2026.
How does Jagsonpal Pharmaceuticals vs Nifty 50 look over 5 years?
Ans. Over five years Jagsonpal Pharmaceuticals has returned +277.1% compared with the Nifty 50’s +29.57%, so in the Jagsonpal Pharmaceuticals vs Nifty 50 comparison the stock has been ahead over this longer horizon.
What is the Jagsonpal Pharmaceuticals share price today compared to Nifty 50?
Ans. Jagsonpal Pharmaceuticals share price stood at Rs 234.71 on NSE, while the Nifty 50 traded at 22,716.20 based on the same closing data window.
What is the 52-week high and low of Jagsonpal Pharmaceuticals?
Ans. Jagsonpal Pharmaceuticals’s 52-week high is Rs 264.50 and its 52-week low is Rs 155.00, based on NSE data.
Why does Jagsonpal Pharmaceuticals show bigger price swings than the Nifty 50?
Ans. Jagsonpal Pharmaceuticals carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Jagsonpal Pharmaceuticals’s price more sharply than the diversified index, a key reason the Jagsonpal Pharmaceuticals vs Nifty 50 return gap varies across time frames.
Is Jagsonpal Pharmaceuticals a good long-term investment compared to a Nifty 50 index fund?
Ans. Jagsonpal Pharmaceuticals’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Jagsonpal Pharmaceuticals vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.
